Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate
about
APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomniaSensitivity and validity of psychometric tests for assessing driving impairment: effects of sleep deprivationAlcohol calibration of tests measuring skills related to car driving.Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.New approaches in the treatment of short term and middle of the night insomnia: emerging evidence for a role for sublingual zolpidem tabletsLow-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakeningsMiddle-of-the-night hypnotic use in a large national health planResidual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.Fast-Acting Sublingual Zolpidem for Middle-of-the-Night Wakefulness.Zolpidem for insomnia.Sublingual zolpidem tartrate lozenge for the treatment of insomnia.Gender influences on efficacy and safety of sublingual zolpidem tartrate for middle-of-the-night awakening in insomnia.Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration.
P2860
Q24644615-E9599C61-F8CD-4C4E-81FE-CCA1C5490782Q28543372-7BEEB1CD-D62C-4AF3-B08E-4AB551F786A2Q33691882-CDFCDF8C-BCF3-4033-8C50-EACCB0747A96Q36526493-640E7817-0DA0-4528-B320-273F332A4562Q36779781-B18BFF1E-E28B-4964-ADF2-8F2B5FDC3B7FQ36891199-A01377AF-357B-4F9F-B6B5-334A4EDFAD21Q36898778-214300B2-372A-4840-8504-B253C252C163Q37576289-B9843052-0F12-4A69-B903-E80377A193B0Q37599340-1C27BD24-A303-4C55-A394-56106DDA7D55Q37994346-350486B3-3564-4E4E-A7DB-8E0FFE5D3A87Q42723601-3DB8E9CB-AE48-46DB-B3FC-1ED9292484A7Q48131659-09125531-E78B-41A7-92F8-B04D19A3B724Q48144743-3BFB4261-7EC1-44D3-B52D-EED4364A6741
P2860
Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Daytime pharmacodynamic and ph ...... smucosal zolpidem hemitartrate
@ast
Daytime pharmacodynamic and ph ...... smucosal zolpidem hemitartrate
@en
type
label
Daytime pharmacodynamic and ph ...... smucosal zolpidem hemitartrate
@ast
Daytime pharmacodynamic and ph ...... smucosal zolpidem hemitartrate
@en
prefLabel
Daytime pharmacodynamic and ph ...... smucosal zolpidem hemitartrate
@ast
Daytime pharmacodynamic and ph ...... smucosal zolpidem hemitartrate
@en
P2093
P2860
P356
P1476
Daytime pharmacodynamic and ph ...... smucosal zolpidem hemitartrate
@en
P2093
Bruce C Corser
David Mayleben
Nikhilesh N Singh
Thomas Roth
P2860
P356
10.1002/HUP.884
P577
2008-01-01T00:00:00Z